- Step therapy, or "fail first," requires you to try one or more lower-cost medications before your plan will cover the drug your prescriber originally chose.
- Insurers use it to control drug spending, and it often mirrors guideline first-line treatments — but critics say it can delay effective care for patients who need a specific drug.
- You or your prescriber can request a step-therapy exception on grounds such as already having tried and failed the required drug, a contraindication, an expected worsening of your condition, or a drug interaction.
- Requests and appeals run on timelines: expedited/urgent reviews are decided quickly (often within about 24 to 72 hours) and standard reviews within a set number of days — check your plan's exact deadlines.
- Medicare matters too: Part D plans can use step therapy in their formularies with an exception process, and Medicare Advantage plans have been allowed since 2019 to apply step therapy to certain Part B (physician-administered) drugs.
- This article is general education, not medical or insurance advice; work with your prescriber and check your specific plan's rules.
What Is Step Therapy in Health Insurance?
Your doctor prescribes a medication, you take it to the pharmacy, and the pharmacist tells you your insurance will not cover it until you try a different drug first. This frustrating scenario is the result of step therapy, a cost-management tool used by health insurers and pharmacy benefit managers. Also known as “fail first” protocols, step therapy requires you to try one or more lower-cost medications before your plan will approve coverage for the drug your prescriber originally chose.
Professional groups such as the American Medical Association have noted that step therapy policies affect a large volume of prescriptions and are among the most common sources of friction between patients, clinicians, and insurers. Understanding how step therapy works, and how to navigate around it when necessary, puts you in a stronger position to get the treatment you need. Always check your own plan’s rules, because they vary widely.
How Step Therapy Works
Step therapy follows a tiered approach. Your insurer establishes a sequence of medications for a given condition, starting with the least expensive option and progressing to more costly alternatives. You must try each “step” and demonstrate that it is ineffective or causes unacceptable side effects before your plan will cover the next option.
For example, if your prescriber recommends a brand-name anti-inflammatory, your insurer might require you to first try a generic option such as ibuprofen or naproxen. If those do not adequately manage your condition, you and your prescriber would document the failure and move to the next step, which might be a prescription-strength alternative. Only after that step also fails would the brand-name medication be approved for coverage. (This is a general illustration of how the tiers work, not a treatment recommendation — your prescriber decides what is appropriate for you.)
The number of required steps varies by condition and insurer. Some protocols have two steps, while complex treatment areas like autoimmune diseases or mental-health conditions may have three or more.
Why Insurers Use Step Therapy
Insurance companies implement step therapy primarily to control prescription-drug costs. Generic and lower-tier medications are significantly cheaper than brand-name or specialty drugs. By requiring patients to start with less expensive options, insurers reduce spending on high-cost prescriptions when a cheaper alternative might work just as well.
From a clinical perspective, step therapy can align with evidence-based medicine. For many conditions, the first-line treatments recommended by medical guidelines are also the less expensive options, so starting with them makes medical sense independent of cost considerations.
However, critics argue that step therapy can prioritize cost savings over individual patient needs. A drug that works well for most patients may not work for a specific patient due to genetic factors, drug interactions, or other conditions. The “fail first” requirement can delay effective treatment. For more on how insurers manage coverage decisions, see our article on prior authorization.
Step Therapy vs. Prior Authorization
Step therapy and prior authorization are related but distinct processes. Prior authorization requires your prescriber to get approval from your insurer before a specific treatment is covered. Step therapy is a specific type of prior authorization that mandates trying alternative treatments first.
A medication might require prior authorization without step therapy. In that case, your prescriber submits documentation supporting the prescription, and the insurer decides whether to approve it based on medical necessity. With step therapy, the insurer adds the further requirement that you must have tried and failed on specific alternative medications before approval is granted.
Conditions Commonly Subject to Step Therapy
Step therapy protocols are most prevalent in therapeutic areas where multiple treatment options exist. These include high cholesterol, where statins have several generic options; depression and anxiety, with numerous generic antidepressants available; chronic pain management; rheumatoid arthritis and other autoimmune conditions; diabetes, particularly for newer injectable medications; and high blood pressure.
Specialty medications, which can cost thousands of dollars per month, are especially likely to have step-therapy requirements. Biologic drugs for conditions like psoriasis, Crohn’s disease, and multiple sclerosis often sit at the final step, requiring patients to try several conventional treatments first.
Step Therapy Under Medicare
Step therapy is not limited to commercial plans — it shows up in Medicare too, with its own rules:
- Medicare Part D: Standalone drug plans and Medicare Advantage plans with drug coverage can build step therapy into their formularies. If a required step is inappropriate for you, you (or your prescriber) can request a coverage determination and, if denied, a formulary exception, followed by the standard Medicare appeals levels.
- Medicare Advantage and Part B drugs: Since 2019, CMS has allowed Medicare Advantage plans to apply step therapy to certain Part B drugs — the physician-administered medications given in a clinic or infusion setting — for new starts, paired with an expedited exception and appeal process. Original Medicare (fee-for-service Part B) does not use step therapy in the same way.
If you are in a Medicare plan, check your plan’s formulary and Evidence of Coverage for the specific step-therapy rules and the exception process, and ask your prescriber to help you request an exception when a required step is not right for you.
How to Request a Step Therapy Exception
If you or your prescriber believe that step therapy is inappropriate for your situation, you can request an exception. Grounds for an exception typically include having already tried and failed the required medications (for example, under a previous plan), medical contraindications that make the lower-step drugs unsafe for you, a condition that could worsen during the time needed to try alternatives, or the required drug being clinically inappropriate due to interactions with your other medications.
To request an exception, your prescriber submits a request to your insurer with supporting clinical documentation. This should include your medical history, the medications you have previously tried, the reasons those medications were ineffective or inappropriate, and clinical evidence supporting the prescribed treatment.
Many states have enacted step-therapy reform laws that require insurers to offer a clear exception process and to grant exceptions under certain circumstances. According to the National Conference of State Legislatures, a large and growing number of states — commonly cited as more than 30 — have adopted some form of step-therapy protections, though the details differ by state and the count changes as new laws pass. State reforms generally apply to state-regulated plans, not to self-funded employer plans governed by federal ERISA rules, so ask which set of rules applies to your coverage.
Exception and Appeal Timelines
Exception requests and appeals run on deadlines. Under many state step-therapy laws and federal rules, plans must respond to a standard request within a set number of business days and to an expedited or urgent request — when waiting could seriously harm your health — much faster, often within about 24 to 72 hours. In Medicare, coverage determinations and appeals have their own standard and expedited timeframes. These windows vary by plan type and state, so confirm the exact deadlines that apply to your plan, and ask for an expedited review if a delay could jeopardize your health.
What to Do If Your Step Therapy Exception Is Denied
If your exception request is denied, you have the right to appeal. The appeals process is similar to appealing any claim denial. Start with an internal appeal, where a different reviewer at your insurance company reconsiders the decision. If the internal appeal fails, request an external review by an independent third party.
During the appeals process, gather comprehensive documentation. A strong appeal includes your prescriber’s letter explaining why the specific medication is necessary, records of prior medication trials and their outcomes, relevant clinical guidelines or medical literature, and a detailed account of how the condition affects your daily life.
Your prescriber’s involvement is critical. Clinicians who provide detailed, condition-specific documentation significantly increase the chances of a successful appeal. Ask your prescriber to write a letter of medical necessity specifically addressing the step-therapy requirement.
The Impact of Step Therapy on Treatment
Research on step-therapy outcomes is mixed. Some studies show that step-therapy protocols reduce healthcare spending without significantly affecting clinical outcomes. Others find that mandatory step therapy can delay effective treatment, contributing to disease progression, emergency-room visits, and higher long-term costs.
For example, a 2019 study published in the Journal of Managed Care and Specialty Pharmacy reported that step therapy for rheumatoid arthritis was associated with higher rates of hospitalization and emergency-department use compared with patients who received their clinician’s first-choice medication. This suggests that for some conditions, the short-term savings from step therapy may be offset by higher costs elsewhere in the system. As with any single study, findings vary by condition and setting.
For patients, the practical impact depends on the specific condition and how quickly alternative medications are tried and evaluated. For conditions that progress rapidly, delays of weeks or months can have meaningful clinical consequences. For stable conditions with multiple well-established treatment options, step therapy may cause minimal disruption.
Frequently Asked Questions
Can my doctor override step therapy?
Your prescriber can request an exception or override, but the insurer makes the final coverage decision. A well-documented exception request with clear clinical justification has a higher chance of approval. If it is denied, you can appeal.
How long does step therapy take?
Each step typically requires trying the medication for a specified period — often 30 to 90 days — before it can be considered a failure. A three-step protocol could therefore take several months to complete before the originally prescribed medication is covered, which is one reason exceptions matter when time is critical.
Does step therapy apply if I switch insurance plans?
Generally, yes. Your new insurer may not recognize medication trials completed under a previous plan unless you provide documentation. This is one of the most common reasons for requesting a step-therapy exception when changing insurance, so keep records of every drug you have tried and how it worked.
Does Medicare use step therapy?
Yes, in specific ways. Part D plans can use step therapy in their formularies with an exception process, and since 2019 Medicare Advantage plans have been allowed to apply step therapy to certain Part B (physician-administered) drugs for new starts, with an expedited exception and appeal process. Check your plan’s formulary and Evidence of Coverage.
Is step therapy legal?
Yes, step therapy is legal, though many states have passed laws requiring insurers to provide clear exception processes and to respond within specific timeframes. Federal rules under the ACA also require insurers to offer internal and external appeals for coverage denials.
Key Takeaway
Step therapy requires you to try lower-cost medications before your insurer will cover the drug your prescriber recommended. While it can reduce costs when a generic alternative works, it can also delay effective treatment. Know your rights: you can request an exception with proper medical documentation, you can ask for an expedited review when a delay could harm your health, and you can appeal a denial through internal and external review. Work with your prescriber to build a strong case, keep records of every medication trial, and check your specific plan — including any Medicare Part D or Part B step-therapy rules — before assuming a drug is off the table. Our healthcare costs guide covers additional strategies for managing prescription and overall healthcare expenses.
Step therapy (“fail first”) makes you try lower-cost drugs before your plan covers the one your prescriber chose. You can request an exception (for a contraindication, a drug you already tried and failed, an interaction, or a condition that could worsen) and appeal a denial, and you can ask for an expedited review when time matters. Medicare has its own rules: Part D formulary step therapy with an exception process, and Medicare Advantage step therapy for certain Part B drugs since 2019. This is general education, not medical or insurance advice — work with your prescriber and check your specific plan’s rules and deadlines.
Sources
- Centers for Medicare & Medicaid Services (CMS) / Medicare.gov — Part D formulary step therapy and coverage-determination/exception rights; Medicare Advantage step therapy for Part B drugs permitted since 2019 with an expedited process
- HealthCare.gov — internal appeal and external review rights for coverage denials
- MedlinePlus — patient guidance on working with your prescriber and plan on medication coverage
- National Conference of State Legislatures (NCSL) — state step-therapy reform and exception-process laws (verify current count and details)